{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:13:29Z","timestamp":1786990409821,"version":"build-2736575974"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100032215","name":"Bamfield Marine Sciences Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032215","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Netherlands Heart Foundation","doi-asserted-by":"publisher","award":["2020B005"],"award-info":[{"award-number":["2020B005"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ijcard.2025.133444","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T19:27:37Z","timestamp":1748892457000},"page":"133444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Genotype-negative hypertrophic cardiomyopathy: Exploring the role of cardiovascular risk factors in disease expression"],"prefix":"10.1016","volume":"437","author":[{"given":"Stephan A.C.","family":"Schoonvelde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar E.","family":"Nollet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter-Paul","family":"Zwetsloot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Knackstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tjeerd","family":"Germans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arend F.L.","family":"Schinkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjon A.","family":"van Slegtenhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith M.A.","family":"Verhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf A.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanda","family":"van der Velden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Michels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ijcard.2025.133444_bb0005","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","article-title":"Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy","volume":"121","author":"Marian","year":"2017","journal-title":"Circ. Res."},{"issue":"14","key":"10.1016\/j.ijcard.2025.133444_bb0010","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.117.033200","article-title":"Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the Sarcomeric human cardiomyopathy registry (SHaRe)","volume":"138","author":"Ho","year":"2018","journal-title":"Circulatio"},{"issue":"7","key":"10.1016\/j.ijcard.2025.133444_bb0015","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMra1710575","article-title":"Clinical course and management of hypertrophic cardiomyopathy","volume":"379","author":"Maron","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.ijcard.2025.133444_bb0020","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","article-title":"Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study","volume":"92","author":"Maron","year":"1995","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ijcard.2025.133444_bb0025","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.amjmed.2003.05.009","article-title":"Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults","volume":"116","author":"Zou","year":"2004","journal-title":"Am. J. Med."},{"issue":"2","key":"10.1016\/j.ijcard.2025.133444_bb0030","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.116.001620","article-title":"Nonfamilial hypertrophic cardiomyopathy: prevalence, natural history, and clinical implications","volume":"10","author":"Ingles","year":"2017","journal-title":"Circ. Cardiovasc. Genet."},{"issue":"2","key":"10.1016\/j.ijcard.2025.133444_bb0035","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3390\/cardiogenetics13020009","article-title":"Sarcomeric versus non-sarcomeric HCM","volume":"13","author":"Borrelli","year":"2023","journal-title":"Cardiogenetics"},{"issue":"19","key":"10.1016\/j.ijcard.2025.133444_bb0040","doi-asserted-by":"crossref","first-page":"10401","DOI":"10.3390\/ijms221910401","article-title":"Genetic testing in patients with hypertrophic cardiomyopathy","volume":"22","author":"Bonaventura","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ijcard.2025.133444_bb0045","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.117.001896","article-title":"Outcomes of contemporary family screening in hypertrophic cardiomyopathy","volume":"11","author":"van Velzen","year":"2018","journal-title":"Circ. Genom. Precis. Med."},{"key":"10.1016\/j.ijcard.2025.133444_bb0050","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pcad.2023.04.009","article-title":"Evolution of genetic testing and gene therapy in hypertrophic cardiomyopathy","volume":"80","author":"Chiswell","year":"2023","journal-title":"Prog. Cardiovasc. Dis."},{"issue":"sup1","key":"10.1016\/j.ijcard.2025.133444_bb0055","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/17431380410032526","article-title":"Family and population strategies for screening and counselling of inherited cardiac arrhythmias","volume":"36","author":"Van Langen","year":"2004","journal-title":"Ann. Med."},{"issue":"3","key":"10.1016\/j.ijcard.2025.133444_bb0060","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.123.004369","article-title":"Integrating clinical phenotype with multiomics analyses of human cardiac tissue unveils divergent metabolic remodeling in genotype-positive and genotype-negative patients with hypertrophic cardiomyopathy","volume":"17","author":"Nollet","year":"2024","journal-title":"Circ. Genom. Precis. Med."},{"issue":"13","key":"10.1016\/j.ijcard.2025.133444_bb0065","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/eurheartj\/ehad028","article-title":"Mitochondrial dysfunction in human hypertrophic cardiomyopathy is linked to cardiomyocyte architecture disruption and corrected by improving NADH-driven mitochondrial respiration","volume":"44","author":"Nollet","year":"2023","journal-title":"Eur. Heart J."},{"issue":"10","key":"10.1016\/j.ijcard.2025.133444_bb0070","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1053\/j.jvca.2024.05.038","article-title":"Evaluating the prevalence of cardiac surgery-associated acute kidney injury after septal myectomy combined with concomitant procedures in obstructive hypertrophic cardiomyopathy","volume":"38","author":"de Wijs","year":"2024","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"issue":"4","key":"10.1016\/j.ijcard.2025.133444_bb0075","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/CIRCGENETICS.113.000331","article-title":"Genotype-positive status in patients with hypertrophic cardiomyopathy is associated with higher rates of heart failure events","volume":"7","author":"Li","year":"2014","journal-title":"Circ. Cardiovasc. Genet."},{"issue":"24","key":"10.1016\/j.ijcard.2025.133444_bb0080","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1136\/heartjnl-2013-303939","article-title":"A systematic review and meta-analysis of genotype\u2013phenotype associations in patients with hypertrophic cardiomyopathy caused by sarcomeric protein mutations","volume":"99","author":"Lopes","year":"2013","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.ijcard.2025.133444_bb0085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/CIRCGENETICS.112.963363","article-title":"Toronto hypertrophic cardiomyopathy genotype score for prediction of a positive genotype in hypertrophic cardiomyopathy","volume":"6","author":"Gruner","year":"2013","journal-title":"Circ. Cardiovasc. Genet."},{"issue":"6","key":"10.1016\/j.ijcard.2025.133444_bb0090","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/ehjci\/jeac233","article-title":"Left ventricular anatomy in obstructive hypertrophic cardiomyopathy: beyond basal septal hypertrophy","volume":"24","author":"Hermida","year":"2023","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"issue":"19","key":"10.1016\/j.ijcard.2025.133444_bb0095","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.jacc.2019.08.1057","article-title":"Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM registry","volume":"74","author":"Neubauer","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10","key":"10.1016\/j.ijcard.2025.133444_bb0100","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.033565","article-title":"Relationship between genotype status and clinical outcome in hypertrophic cardiomyopathy","volume":"13","author":"Bonaventura","year":"2024","journal-title":"J. Am. Heart Assoc."},{"issue":"17","key":"10.1016\/j.ijcard.2025.133444_bb0105","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1161\/CIRCULATIONAHA.119.044366","article-title":"Hypertrophic cardiomyopathy with left ventricular systolic dysfunction: insights from the SHaRe registry","volume":"141","author":"Marstrand","year":"2020","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ijcard.2025.133444_bb0110","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2020-001560","article-title":"Sarcomere mutation negative hypertrophic cardiomyopathy is associated with ageing and obesity","volume":"8","author":"de Feria","year":"2021","journal-title":"Open Heart"},{"issue":"2","key":"10.1016\/j.ijcard.2025.133444_bb0115","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41588-020-00764-0","article-title":"Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity","volume":"53","author":"Harper","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ijcard.2025.133444_bb0120","series-title":"Mayo Clin Proceed","article-title":"Characterization of a phenotype-based genetic test prediction score for unrelated patients with hypertrophic cardiomyopathy","year":"2014"},{"issue":"2","key":"10.1016\/j.ijcard.2025.133444_bb0125","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/ehjqcco\/qcae092","article-title":"Loss of quality of life and increased societal costs in patients with hypertrophic cardiomyopathy: the AFFECT-HCM study","volume":"11","author":"Schoonvelde","year":"2025","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes"},{"issue":"5","key":"10.1016\/j.ijcard.2025.133444_bb0130","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"issue":"37","key":"10.1016\/j.ijcard.2025.133444_bb0135","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC Guidelines for the management of cardiomyopathies: developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC)","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.ijcard.2025.133444_bb0140","first-page":"19","article-title":"Cardiovascular risks associated with gender and aging","volume":"6","author":"Rodgers","year":"2019","journal-title":"J. Cardiovasc. Dev. Dis."},{"issue":"16","key":"10.1016\/j.ijcard.2025.133444_bb0145","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1177\/2047487316648474","article-title":"A comparison of the prevalence and clustering of major cardiovascular risk factors in the Netherlands and China","volume":"23","author":"Wang","year":"2016","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2025.133444_bb0150","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/ehjqcco\/qcac006","article-title":"Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy\/Myocarditis registry","volume":"9","author":"Lopes","year":"2023","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes"},{"key":"10.1016\/j.ijcard.2025.133444_bb0155","series-title":"Mayo Clin Proc","article-title":"Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: Septal morphological features predict the presence of myofilament mutations","year":"2006"},{"key":"10.1016\/j.ijcard.2025.133444_bb0160","article-title":"Evaluation of potential links between phenotypic features and genetic variants in left ventricular outflow tract obstruction in hypertrophic cardiomyopathy using cardiovascular magnetic resonance imaging","volume":"1-12","author":"G\u00fcven","year":"2024","journal-title":"Int. J. Card. Imaging"},{"issue":"3","key":"10.1016\/j.ijcard.2025.133444_bb0165","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1152\/physrev.00024.2022","article-title":"Genome-wide association studies of cardiovascular disease","volume":"103","author":"Walsh","year":"2023","journal-title":"Physiol. Rev."},{"issue":"22","key":"10.1016\/j.ijcard.2025.133444_bb0170","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018641","article-title":"Unraveling the genotype-phenotype relationship in hypertrophic cardiomyopathy: obesity-related cardiac defects as a major disease modifier","volume":"9","author":"Nollet","year":"2020","journal-title":"J. Am. Heart Assoc."},{"issue":"9","key":"10.1016\/j.ijcard.2025.133444_bb0175","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1042\/CS20160485","article-title":"Mitochondria: a central target for sex differences in pathologies","volume":"131","author":"Ventura-Clapier","year":"2017","journal-title":"Clin. Sci."},{"issue":"6","key":"10.1016\/j.ijcard.2025.133444_bb0180","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004133","article-title":"Sex differences at the time of myectomy in hypertrophic cardiomyopathy","volume":"11","author":"Nijenkamp","year":"2018","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcard.2025.133444_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.612215","article-title":"Sex-related differences in protein expression in sarcomere mutation-positive hypertrophic cardiomyopathy","volume":"8","author":"Schuldt","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"25","key":"10.1016\/j.ijcard.2025.133444_bb0190","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000912","article-title":"Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American Heart Association","volume":"142","author":"El Khoudary","year":"2020","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ijcard.2025.133444_bb0195","doi-asserted-by":"crossref","DOI":"10.1530\/EC-21-0537","article-title":"Menopause-associated risk of cardiovascular disease","volume":"11","author":"Anagnostis","year":"2022","journal-title":"Endocr. Connect."},{"issue":"40","key":"10.1016\/j.ijcard.2025.133444_bb0200","doi-asserted-by":"crossref","first-page":"16571","DOI":"10.1074\/jbc.M117.776815","article-title":"A small-molecule modulator of cardiac myosin acts on multiple stages of the myosin chemomechanical cycle","volume":"292","author":"Kawas","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"10253","key":"10.1016\/j.ijcard.2025.133444_bb0205","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.ijcard.2025.133444_bb0210","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1056\/NEJMoa2401424","article-title":"Aficamten for symptomatic obstructive hypertrophic cardiomyopathy","volume":"390","author":"Maron","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ijcard.2025.133444_bb0215","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.125.005100","article-title":"Long-term effects of Mavacamten on patients based on hypertrophic cardiomyopathy pathogenic genetic variant status: insights from VALOR-HCM trial","volume":"18","author":"Desai","year":"2025","journal-title":"Circ. Genom. Precis. Med."},{"key":"10.1016\/j.ijcard.2025.133444_bb0220","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ahj.2024.07.001","article-title":"The impact of mavacamten dosing on wall thickness regression: an insight from longer term follow-up based on genetic profile","volume":"277","author":"Alsidawi","year":"2024","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2025.133444_bb0225","series-title":"Mayo Clin Proc","article-title":"Genotype influences Mavacamten responsiveness in obstructive hypertrophic cardiomyopathy","year":"2024"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527325004875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527325004875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:56:40Z","timestamp":1762253800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527325004875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":45,"alternative-id":["S0167527325004875"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2025.133444","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genotype-negative hypertrophic cardiomyopathy: Exploring the role of cardiovascular risk factors in disease expression","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2025.133444","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"133444"}}